ATG01

Beta-2-Glycoprotein 1

Native - Human Plasma

Alternate Names:

Apolipoprotein H | APOH | Activated protein C-binding protein | APC inhibitor

Uniprot IDs:
mRNA RefSeq:
Protein RefSeq:

Want to see pricing and place an order?

Register and then log-in

Have an enquiry about this product?

Go here

Product Information

Autoantibodies directed to negatively charged phospholipids, in particular cardiolipin, have been detected in the serum of patients with systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS). APS is characterised by venous and arterial thrombosis, recurrent spontaneous abortions and thrombocytopenia. It is now known that a serum cofactor, β2-glycoprotein 1, is required for the binding of cardiolipin by autoantibodies in the sera of patients with APS. By contrast, anticardiolipin antibodies from patients with infectious diseases (in particular, syphilis) do not require this cofactor.

β2-Glycoprotein 1, also known as apolipoprotein H, is a relatively abundant serum protein (present at a concentration of about 0.2 mg/ml) that may play a role in coagulation. It has been shown to bind to platelets, mitochondria and negatively charged substances such as heparin, DNA, dextran sulphate and negatively charged phospholipids.

β2-Glycoprotein 1 is known to be very heat stable. On SDS-electrophoresis the protein displays an apparent molecular weight of ~55 kDa reduced and ~45kDa in non-reduced conditions. Isoelectric focussing has been reported to reveal genetic polymorphisms of β2-glycoprotein 1, the multiple bands seen by this method may be due to different amounts of sialic acid. The amino acid sequence of β2-glycoprotein 1 reveals a 326 amino acid protein of about 36 kDa. This sequence has been confirmed by sequencing the protein’s cDNA. The fact that the protein migrates on SDS-electrophoresis with a much larger apparent m.wt., suggests that it is extensively glycosylated. β2-Glycoprotein 1 has five consensus repeats, referred to as "Sushi domains", characteristic of the complement control protein family.

Clinical Indications

Antiphospholipid Syndrome 
Systemic Lupus Erythematosus

Certificate of Analysis

Please log in to view certificates of analysis for this item

References

    1. Hughes, G.R.V. (1994) Lancet 342, 341
    2. Galli, M. et al. (1990) Lancet 335, 1544
    3. Matsuura, E. et al. (1990) Lancet 336, 177
    4. McNeil, H.P. et al. (1991) Proc. Natl. Acad. Sci. USA 87, 4120
    5. Matsuura, E. et al. (1992) J. Immunol. 148, 3885
    6. Schousboe, I. (1985) Blood 66, 1086
    7. Schousboe, I. (1980) Thromb. Res. 19, 225
    8. Schousboe, I. (1979) Biochim. Biophys. Acta 579, 396
    9. Polz et al. (1980) Int. J. Biochem. 11, 265
    10. Kroll, J. et al. (1976) Biochim. Biophys. Acta 434, 490
    11. Schousboe, I. & Rasmussen, M.S. (1988) Int. J. Biochem. 20, 787
    12. Wurm, H. (1984) Int. J. Biochem. 16, 511
    13. Richter, A. & Cleve, H. (1988) Electrophoresis 9, 317
    14. Gries, A. et al. (1989) Biochem. J. 260, 531
    15. Lozier, J. et al. (1984) Proc. Natl. Acad. Sci. USA 81, 3640
    16. Steinkasserer, A. et al. (1991) Biochem. J. 277, 387
    17. Kato, H. & Enjyoji, K. (1991) Biochem. USA 30, 11687
    18. Ichinose, A. et al. (1990) J. Biol. Chem. 265, 13411
    19. Amiral, J. et al. (1994) Haemostasis 24, 191
    20. Arvieux, J. et al. (1991) J. Immunol. Methods 143, 223
    21. Cabral, A.R. et al. (1992) J. Autoimmunity 5, 787
    22. El-Kadi, H.S. et al. (1995) J. Rheumatol. 22, 2233
    23. Erickson, E.N. et al. (1996) Clin. Chem. 42, 1116
    24. Gharavi, A.E. et al. (1993) J. Lab. Clin. Med. 122, 426
    25. Hanly, J.G. et al. (1995) J. Rheumatol. 22, 1091
    26. Hunt, J. & Krilis, S. (1994) J. Immunol. 152, 653
    27. Katano, K. et al. (1996) Human Reprod. 11, 509
    28. Keil, L.B. et al. (1995) Biotechnol. Appl. Biochem. 22, 305
    29. Martinuzzo, M.E. et al. (1995) Brit. J. Haemotol. 89, 397
    30. Matsuura, E. et al. (1992) J. Immunol. 148, 3885
    31. McNally, T. et al. (1995) Brit. J. Haematol. 91, 471
    32. Nomura, M. et al. (1995) Rheumatol. Int. 15, 1
    33. Pengo, V. et al. (1995) Thrombosis & Haemostasis 73, 29
    34. Roubey, R.A.S. et al. (1995) J. Immunol. 154, 954
    35. Matsuura, E. et al. (1994) J. Exp. Med. 179, 457
    36. Arvieux, J. & Roussel, B. (1994) Brit. J. Haemotol. 88, 443
    37. Matsuda, J. et al. (1993) Brit. J. Haemotol. 85, 799
    38. Cheng, H.W. (1996) J. Immunol. Methods 191, 87

After a custom reagent?

Need to discuss specific protein requirements. Our team can help create tailored solutions to meet your diagnostic needs.